ELIZABETH GENE BAUMANN

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology GAINESVILLE, FL NPI 1013594225

General Payments — all program years on this page

$2,271.09

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 36
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $853.75 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $853.7519

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $221.682
Amgen Inc. $190.7912
Alexion Pharmaceuticals, Inc. $167.392
Neurelis, Inc. $124.991
TG THERAPEUTICS, INC. $123.991
LivaNova USA, Inc. $24.911

By program year

Program yearAmountRecords
2022 $855.9211
2023 $561.426
2024 $853.7519

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1110508316 AstraZeneca Pharmaceuticals LP $126.43 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110510278 AstraZeneca Pharmaceuticals LP $95.25 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110512696 Alexion Pharmaceuticals, Inc. $35.31 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110514498 Alexion Pharmaceuticals, Inc. $132.08 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111526174 Amgen Inc. $31.18 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111526176 Amgen Inc. $13.62 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111526178 Amgen Inc. $13.30 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111526180 Amgen Inc. $1.74 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111526182 Amgen Inc. $12.91 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111526184 Amgen Inc. $14.61 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111526186 Amgen Inc. $15.15 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111526188 Amgen Inc. $10.22 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111526190 Amgen Inc. $4.91 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111526192 Amgen Inc. $25.45 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111526194 Amgen Inc. $22.20 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111526196 Amgen Inc. $25.50 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136886670 TG Therapeutics, Inc. $123.99 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145633257 Neurelis, Inc. $124.99 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152789513 LivaNova USA, Inc. $24.91 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.